Telesis Bio, Inc. - Common Stock (TBIO)

$4.59 0.09 (2.00%)

11:04 EDT TBIO Stock Quote Delayed 30 Minutes

TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings May 9, 2024

TBIO stock results show that Telesis Bio missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q4 2023

More Articles

Volume:

Previous Close -

Market Cap 346.94M

PE Ratio 7.78

EPS 0.59

Volume (Avg. Vol.) 7,184

Day's Range $4.36 - $4.69

52-Week Range $0.28 - $6.40

Dividend & Yield N/A (N/A)

TBIO Stock Predictions, Articles, and Telesis Bio, Inc. - Common Stock News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Feb 26, 2024

We're starting the trading week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Why Is Telesis Bio (TBIO) Stock Up 29% Today?

By William White, InvestorPlace Writer Feb 23, 2024

Telesis Bio stock is heading higher on Friday with heavy trading of TBIO shares despite a lack of news from the company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Feb 23, 2024

It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jan 22, 2024

We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Nov 27, 2023

It's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Mar 22, 2023

The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning!

7 Disruptive Biotech Stocks to Buy for 2025

By Harriet Lefton, Writer, TipRanks Apr 27, 2020

RBC Capital has peered into its crystal ball to reveal some of the market's most exciting biotech stocks. Here are seven that stand out.

7 Biotech Stocks to Buy That Could Beat the Coronavirus

By Chris Lau, InvestorPlace Contributor Apr 1, 2020

These biotech stocks are all working on treatments that have the potential to beat the coronavirus. Don't just wait for a cure. Buy them now.

5 “Strong Buy” Biotech Stocks With More Than 80% Upside

By Maya Sasson, Writer, TipRanks Nov 27, 2019

For investors seeking out the ultimate high-risk, high-reward stocks, look no further than the biotech industry.

Telesis Bio announces 26.3% drop in prelim Q4 revenue (NASDAQ:TBIO)

From Seeking Alpha Feb 26, 2024

Telesis Bio expects a 26.3% reduction in Q4 2023 revenue due to lower-priced instruments and weakness in end markets.

Telesis Bio appoints William Kullback as CFO (NASDAQ:TBIO)

From Seeking Alpha Aug 29, 2023

Telesis Bio (TBIO) on Tuesday has named William Kullback as its Chief Financial Officer, effective August 28. Prior to joining Telesis Bio, Kullback served for over five years as...

BofA lowers rating on Telesis Bio to sector weight from overweight (NASDAQ:TBIO)

From Seeking Alpha Aug 11, 2023

BofA has lowered its rating of Telesis Bio (TBIO) to sector weight from overweight, citing in part a slowdown in biopharma spending."Facing a tepid biopharma spending environment, we...

Telesis Bio gets $28 million in financing through preferred stock private placement (TBIO)

From Seeking Alpha May 31, 2023

Telesis Bio (NASDAQ:TBIO) said Wednesday it has signed an agreement with institutional investors to provide the company with funding of $28 million through a private placement of...

Director Of Translate Bio Sold $78.09 Million In Stock

From Benzinga Sep 15, 2021

Jean-Francois Formela, Director at Translate Bio (NASDAQ:TBIO), made a large insider sell on September 14, according to a new SEC filing. What Happened: A Form 4 filing from the...

3 Stocks Insiders Are Buying

From Benzinga Sep 15, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

ADVERTISEMENT